rs78427072
Variant summary
Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_001384474.1(LOXHD1):c.4720G>A(p.Glu1574Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000432 in 1,551,744 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001384474.1 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive nonsyndromic hearing loss 77Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics
- nonsyndromic genetic hearing lossInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Fuchs' endothelial dystrophyInheritance: AD Classification: LIMITED Submitted by: Illumina
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -13 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| LOXHD1 | NM_001384474.1 | c.4720G>A | p.Glu1574Lys | missense_variant | Exon 30 of 41 | ENST00000642948.1 | NP_001371403.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| LOXHD1 | ENST00000642948.1 | c.4720G>A | p.Glu1574Lys | missense_variant | Exon 30 of 41 | NM_001384474.1 | ENSP00000496347.1 |
Frequencies
GnomAD3 genomes AF: 0.00225 AC: 342AN: 152224Hom.: 2 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.000424 AC: 67AN: 157908 AF XY: 0.000337 show subpopulations
GnomAD4 exome AF: 0.000234 AC: 327AN: 1399402Hom.: 0 Cov.: 32 AF XY: 0.000190 AC XY: 131AN XY: 690206 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00225 AC: 343AN: 152342Hom.: 2 Cov.: 33 AF XY: 0.00208 AC XY: 155AN XY: 74498 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.4720G>A (p.E1574K) alteration is located in exon 30 (coding exon 30) of the LOXHD1 gene. This alteration results from a G to A substitution at nucleotide position 4720, causing the glutamic acid (E) at amino acid position 1574 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not specified Benign:1
p.Glu1574Lys in exon 30 of LOXHD1: This variant is not expected to have clinical significance because it has been identified in 0.8% (23/2750) of African chromo somes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs78427072). -
not provided Benign:1
- -
LOXHD1-related disorder Benign:1
This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at